...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: From CRP to IL-6 to IL-1: Moving Upstream To Identify Novel Targets for Atheroprotection

BDZ, thanks very much for your response.  I did of course read last month’s evolution post, and while the other two were before my time they definitely contributed to my overall understanding.

Unfortunately it seems there is no way we can confidently predict a positive outcome prior to the release of topline results.....which is somewhat of a bummer. :). So yes......tick tock indeed.

Share
New Message
Please login to post a reply